CAS Tianjin Institute of Industrial Biotechnology (TIB) signs erythromycin project with industrial consortium

The consortium comprises leading antibiotic produceers such as the Tonglian Group and Shenyang’s Chinese Academy of Technology. TIB’s HTS screening platform will be used to arrive at higher yields of the antibiotic of which China is already a major producer

CAS news release, April 12, 2016

CAS Tianjin Institute of Industrial Biotechnology (TIB) signs erythromycin project with industrial consortium
Scroll to top